Structure Therapeutics Inc. (GPCR)
Market Closed
9 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
66. 70
-3.28
-4.68%
$
1.99B Market Cap
- P/E Ratio
0% Div Yield
3,491,872 Volume
- Eps
$ 69.98
Previous Close Day Range
66.15 71.99
Year Range
13.22 94.9
Want to track GPCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 78 days
Structure Therapeutics (GPCR) Stock Soars 60% on Weight Loss Drug Success
Structure Therapeutics (NASDAQ: GPCR ) stock is surging today, up 60% after the biotech company reported promising results of its mid-stage trials for its weight loss pills. Indeed, after 12 weeks, patients on the treatment lost an average of 6.2% of their weight, with one-third of patients losing more than 10% of their weight.
Investorplace | 1 year ago
Structure Therapeutics Stock Skyrockets To Six-Month High On Compelling Weight-Loss Drug Results
Structure Therapeutics stock roses sharply Monday after the biotech company delivered "compelling" results for its weight-loss drug.
Investors | 1 year ago
Structure Therapeutics' stock jumps on weight-loss-pill trial results
Structure Therapeutics Inc.'s American depositary receipts GPCR, +1.30% gained more than 6% premarket on Monday after the company said its experimental weight-loss pill achieved its aims in a clinical trial.
Marketwatch | 1 year ago
2025 © Marketlog. All Rights Reserved.
